Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Epithelial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02613156
What this trial is testing

Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma

Who this might be right for
Recurrent Hepatocellular Carcinoma
Sun Yat-sen University 25
Early research (Phase 1)Ended earlyNCT00828594
What this trial is testing

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 130
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02795156
What this trial is testing

Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

Who this might be right for
Non-small Cell Lung CarcinomaUrothelial CarcinomaGastrointestinal Carcinoma, Non-colon+1 more
SCRI Development Innovations, LLC 100
Not applicableStudy completedNCT00683631
What this trial is testing

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Louisville 183
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06452602
What this trial is testing

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableStudy completedNCT06550739
What this trial is testing

Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Haike Lei 1,053
Large-scale testing (Phase 3)UnknownNCT04797884
What this trial is testing

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
THERABIONIC INC. 166
Early research (Phase 1)WithdrawnNCT07365839
What this trial is testing

Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Virginia Commonwealth University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07618910
What this trial is testing

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tang-Du Hospital 33
Not applicableLooking for participantsNCT05935189
What this trial is testing

Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens

Who this might be right for
Hepatocellular Carcinoma
Nikomed Medical Center 500
Testing effectiveness (Phase 2)Ended earlyNCT00109850
What this trial is testing

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 22
Testing effectiveness (Phase 2)Looking for participantsNCT05185739
What this trial is testing

Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University College, London 60
Not applicableLooking for participantsNCT06898398
What this trial is testing

TACE Combined Surgery for the Resectable Huge HCC

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer+1 more
Sun Yat-sen University 326
Early research (Phase 1)Study completedNCT01264432
What this trial is testing

Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer

Who this might be right for
Adult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Large-scale testing (Phase 3)Ended earlyNCT01740375
What this trial is testing

Role of Esophagectomy in Complete Responders to CCRT

Who this might be right for
Esophageal Squamous Cell Carcinoma
Asan Medical Center 486
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Next Page